Spots Global Cancer Trial Database for A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Official Title: A Randomized, Open-Label, Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-Recurrent-Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, or Fallopian Tube Cancer Following Complete Remission With First-Line Chemotherapy
Study ID: NCT01685255
Study Description
Brief Summary: This is an open-label, randomized, phase 2 study of an IDO inhibitor, INCB024360 (epacadostat) versus tamoxifen in biochemical recurrent only ovarian cancer patients following complete remission with first-line chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
, La Jolla, California, United States
, Los Angeles, California, United States
, San Francisco, California, United States
, Evanston, Illinois, United States
, Joliet, Illinois, United States
, Iowa City, Iowa, United States
, Covington, Louisiana, United States
, Baltimore, Maryland, United States
, Detroit, Michigan, United States
, Minneapolis, Minnesota, United States
, Bridgewater, New York, United States
, Buffalo, New York, United States
, Mineola, New York, United States
, Durham, North Carolina, United States
, Abington, Pennsylvania, United States
, Philadelphia, Pennsylvania, United States
, Greenville, South Carolina, United States
, Bendigo, , Australia
, Heidelberg, , Australia
, Herston, , Australia
, Milton, , Australia
, Randwick, , Australia
, Calgary, Alberta, Canada
, Toronto, Ontario, Canada
, Montreal, Quebec, Canada
, Ekaterinburg, , Russian Federation
, Izhevsk, , Russian Federation
, Krasnodar, , Russian Federation
, Kursk, , Russian Federation
, Moscow, , Russian Federation
, Orenburg, , Russian Federation
, St. Petersburg, , Russian Federation
, Ufa, , Russian Federation
, Chernivtsi, , Ukraine
, Dnepropetrovsk, , Ukraine
, Kharkiv, , Ukraine
, Lutsk, , Ukraine
, Bebington, , United Kingdom
, Cardiff, , United Kingdom
, Edinburgh, , United Kingdom
, Glasgow, , United Kingdom
, Keighley, , United Kingdom
, Leeds, , United Kingdom
, Liverpool, , United Kingdom
, London, , United Kingdom
, Manchester, , United Kingdom
, Nottingham, , United Kingdom
, Oxford, , United Kingdom
, West Midlands, , United Kingdom
Contact Details
Name: Lance Leopold, M.D.
Affiliation: Incyte Corporation
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
